Stanford Health Care.
San Jose State University.
Oncol Nurs Forum. 2022 May 1;49(3):233-241. doi: 10.1188/22.ONF.233-241.
To evaluate the effects of virtual reality (VR) on symptom distress, such as depression, anxiety, and pain, experienced by individuals receiving allogeneic hematopoietic stem cell transplantation.
SAMPLE & SETTING: 20 participants aged 19-70 years (median age of 56.5 years) who were hospitalized in an academic setting received as many as two sessions of VR per week for two weeks.
METHODS & VARIABLES: Before and after each session, participants completed the revised Edmonton Symptom Assessment Scale (ESAS-r) to evaluate their symptoms. Paired t tests were later conducted.
VR sessions showed significant improvement in 8 of the 10 symptoms addressed in ESAS-r.
VR can improve symptoms in patients following hematopoietic stem cell transplantation in a hospital setting, provide a low-cost intervention to treat symptoms, and support future investigations exploring how VR affects prolonged hospitalizations related to distressing symptoms.
评估虚拟现实 (VR) 对接受异基因造血干细胞移植的个体所经历的症状困扰（如抑郁、焦虑和疼痛）的影响。
20 名年龄在 19-70 岁之间（中位年龄 56.5 岁）的参与者在学术环境住院，每周接受多达两次、为期两周的 VR 治疗。
在每次治疗前后，参与者使用修订后的 Edmonton 症状评估量表 (ESAS-r) 评估他们的症状。随后进行了配对 t 检验。
VR 治疗显示 ESAS-r 中 10 个症状中有 8 个得到显著改善。
在医院环境中，VR 可以改善造血干细胞移植患者的症状，为治疗症状提供一种低成本的干预措施，并支持未来的研究，探索 VR 如何影响与痛苦症状相关的延长住院时间。
